Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction

Circulation

Volumn 97, Issue 8, 1998, Pages 765-772

  Wu, Katherine C ^a   Zerhouni, Elias A ^a   Judd, Robert M ^b   Lugo Olivieri, Carlos H ^a   Barouch, Lili A ^a   Schulman, Steven P ^a   Blumenthal, Roger S ^a   Lima, João A C ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Magnetic resonance imaging; Microcirculation; Prognosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HUMAN; MICROCIRCULATION; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032478098     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.8.765     Document Type: Article

References (57)

1. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
2. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Gianni T. the Ad hoc Working Group for the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data base. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation. 1993;88:416-429.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase. oral aspirin, both or neither among 17.187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
4. Guerci AD, Gerstenblith G, Brinker JA, Chandra NC, Gottlieb SO, Bahr RD, Weiss JL, Shapiro EP, FlahertyJT, Bush DE, Chew PH, Gottlieb SH, Halperin HR, Ouyang P, Walford GD, Bell WR, Fatterpaker AK, Llewellyn M, Topol EJ, Healy B, Siu CO, Becker LC, Weisfeldt ML. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987;317:1613-1618.
5. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99m-Tc sestamibi imaging predicts subsequent mortality. Circulation. 1995;92:334-341.
6. Lima JAC, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Circulation. 1995;92:1117-1125.
7. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JAC, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995;92:1902-1910.
8. Goldman MR, Brady TJ, Pykett IL, Burt CT, Buonanno FS, Kistler P, NewhouseJH, Hinshaw WS, Pohost GM. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation. 1982;66:1012-1016.
9. Holman ER. van Jongergen HPW, van Dijkman RM, van der Laarse A, de Roos A, van der Wall E. Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol. 1993;71:1036-1040.
10. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis, Circulation. 1992;85:1699-1705.
11. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembock IJ, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation. 1994;89:2562-2569.
12. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54: 1496-1508.
13. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861.
14. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the 'noreflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.
15. Marino P, Zanolla L, Zardini P. on behalf of GISSI. Effect of streptokinase on left ventricular remodeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. J Am Coll Cardiol. 1989;14:1149-1158.
16. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
17. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, Lamas GA, Klein M, Sussex M, Goldman S, Menapace FJ, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E. for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction: the protective effects of captopril. Circulation. 1994;89:68-75.
18. Erlebacher JA, Weiss JL, Eaton JW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: a two-dimensional echocardiographic study. Am J Cardiol. 1982;49:1120-1126.
19. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Corne PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693-702.
20. Lamas GA, Pfeffer MA. Increased left ventricular volume following myocardial infarction in man. Am Heart J. 1986;11:30-35.
21. Seals AA, Pratt CM, Mahmarian JJ, Tadros S, Kleiman N, Roberts R, Verani MS. Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size, and location. Am J Cardiol. 1988;61:224-229.
22. Bulkley BJ, Roberts WC. Steroid therapy during acute myocardial infarction: a cause of delayed healing and of ventricular aneurysm. Am J Med. 1974;56:244-250.
23. Hammerman H, Schoen FJ, Braunwald E, Kloner RA. Drug-induced expansion of infarct: morphologic and functional correlations. Circulation. 1984;69:611-617.
24. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulatian. 1987;75: 299-306.
25. Lavie CJ, O'Keefe JH, Chesebro JH, Clements IP, Gibbons RJ. Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion. Am J Cardiol. 1990;66:31-46.
26. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1993;21:683-691.
27. Ito H, Okamura A, Iwakura K, Masuyama T, Hori M, Takiuchi S, Negoro S, Nakatsuchi Y, Taniyama Y, Higashino Y, Fujii K, Minamino T. Myocardial perfusion patterns related to Thrombolysis in Myocardial Infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation. 1996;93:1993-1999.
28. Chesebro JH. Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison berween intraVenous tissue plasminogen activator and intravenous streptokinase. Circulation. 1987;76:142-154.
29. Judd RM, Reeder SB, Atalar E, McVeigh ER, Zerhouni EA. A magnetization-driven gradient echo pulse sequence for the study of myocardial perfusion. Magn Reson Med. 1995;34:276-282.
30. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelmann R. First-pass nuclear magnetic resonance imaging studies of patients with coronary artery disease. J Am Coll Cardiol. 1991;18:959-965.
31. 18F]fluorodeoxyglucose in patients with chronic coronary artery disease. Circulation. 1995;91:1006-1015.
32. Reichek N, Helak J, Plappert T, St John Sutton M, Weber KT. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation. 1983;67:348-352.
33. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: McGraw Hill; 1971:351-359.
34. Kim RJ, Chen E, Lima JAC, Judd RM. Myocardial Gd-DTPA kinetics detennine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94: 3318-3326.
35. Rochitte CE, Lima JAC, Reeder SP, McVeigh ER, Bluemke DA, Furuta T, Becker LC, Melin JA. Microvascular obstruction propresses beyond coronary occlusion and reflow after acute experimental infarction. J Am Coll Cardiol. 1997;29:215A. Abstract.
36. Schofer J, Montz R, Mathey DG, Scintigraphic evidence of the 'no-reflow' phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol. 1985;5:593-598.
37. Jeremy RW, Links JM. Becker LC. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol. 1990;16:695-704.
38. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol. 1995;25:1333-1340.
39. Christian TF, Behrenbeck T, Gersh BJ, Gibbons RJ. Relation of left ventricular volume and function over one year after acute myocardial infarction to infarct size determined by technetium-99m sestamibi. Am J Cardiol. 1991;68:21-26.
40. braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation, 1982;66:1146-1149.
41. Grines CL, Topol EJ, Califf RM, Stack RS, George BS, Kereiakes D, Boswick JM, Kline E, O'Neill WW. and the TAMI Study Group. Prognoetic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. Circulation, 1989;80:245-253.
42. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation. 1987;76:1422-1436.
43. Califf RM, Harrelson-Woodlief L, Topol EJ. Left ventricular ejection fraction may not be useful as an endpoint of thrombolytic therapy comparative trials. Circulation. 1990;82:1847-1853.
44. Komrad MS, Coffey CE, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology. 1984;34:1403-1409.
45. Maggioni AP, Franzosi MG, Farina ML, Santoro E, Celani MG, Ricci S, Tognoni G. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. BMJ. 1991;302:1428-1431.
46. Loh E, St John Sutton M, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336: 251-257.
47. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
48. O'Connor MK. Hammeil T. Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med. 1990;17:69-76.
49. Dixon WT, Oshinski JN, Trudeau JD, Arnold BC, Pettigrew RI. Myocardial suppression in vivo by spin locking with composite pulses. Magn Resen Med. 1996;36:90-94.
50. Poncelet B, Weisskoff RW, Wedeen VJ, Brady TJ, Kantor HK. Time of flight quantification of coronary flow with echo-planar MRI. Magn Reson Med. 1993;30:447-457.
51. Ehman RL, Felmlee JP. Adaptive techniques for high definition MR imaging of moving structures. Radiology, 1989;173:255-263.
52. Kramer CM, Lima JA, Reichek N, Ferrari VA, Llaneras MR, Palmon LC, Yeh IT, Tallant B, Axel L. Regional differences in function within noninfarcted myocardium during left ventricular remodeling. Circulation. 1993; 88:1279-1288.
53. 23Na magnetic resonance imaging of acute reperfused myocardial infarction: potential to assess myocardial viability. Circulation. 1997;95: 1877-1885.
54. Manning WJ, Li W, Edelman RR. A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med. 1993;328:828-832.
55. Clarke GD, Eckels R, Chaney C, Smith D, Dittrich J, Hundley WG, NessAiver M, Li HFm Parkey RW, Peshock RM. Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging, Circulation. 1995;91:2627-2634.
56. White HD, Norris RM, Brown MA, Takayama M, Maslowski A, Bass NG, Ormiston JA, Whitlock T. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med. 1987;317:850-855.
57. Schulman SP, Goldschmidt-Clermont PJ, Topol EJ, Califf RM, Navetta FI, Willerson JT, Chandra NC, Guerci AD, Ferguson JJ, Harrington RA, Lincoff M, Yakubov SJ, Bray PF, Bahr RD, Wolfe CL, Yock PG, Anderson V, Nygaard TW, Mason SJ, Effron MB. Fatterpacker A, Raskin S, Smith J, Brashears L, Gottdiener P, du Mee C, Kitt MM, Gerstenblith G. Effects of imegrelin. a platelet glycoprotein II/b IIIa receptor antagonist, in unstable angina: a randomized multicenter trial. Circulation. 1996;94: 2083-2089.